Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis

Front Immunol. 2023 Dec 22:14:1275001. doi: 10.3389/fimmu.2023.1275001. eCollection 2023.

Abstract

Significance: This review discusses the coronavirus disease 2019 (COVID-19) pathophysiology in the context of diabetes and intracellular reactions by COVID-19, including mitochondrial oxidative stress storms, mitochondrial ROS storms, and long COVID.

Recent advances: The long COVID is suffered in ~10% of the COVID-19 patients. Even the virus does not exist, the patients suffer the long COVID for even over a year, This disease could be a mitochondria dysregulation disease.

Critical issues: Patients who recover from COVID-19 can develop new or persistent symptoms of multi-organ complications lasting weeks or months, called long COVID. The underlying mechanisms involved in the long COVID is still unclear. Once the symptoms of long COVID persist, they cause significant damage, leading to numerous, persistent symptoms.

Future directions: A comprehensive map of the stages and pathogenetic mechanisms related to long COVID and effective drugs to treat and prevent it are required, which will aid the development of future long COVID treatments and symptom relief.

Keywords: COVID-19; long Covid; mitochondria; mitochondrial ROS storms; oxidative stress.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Mitochondria
  • Oxidative Stress
  • Post-Acute COVID-19 Syndrome*
  • Reactive Oxygen Species

Substances

  • Reactive Oxygen Species

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the COVID-19 Kitasato project and a grant from Kitasato University School of Allied Health Sciences (Grant-in-Aid for Research Project, No. 2022-1013) and in part, supported by Walailak University.